Biomarkers of Cardiovascular Risk: State of the Art

Biomarkers of Cardiovascular Risk

October 30-31, 2007

Contact Information

Mayo Medical Laboratories
Education Department

E-Mail Address
Phone: 800.533.1710
Fax: 507.284.8016
Global: 507.284.3156

Biomarkers of Cardiovascular Risk:

State of the Art

Conference Faculty

Course Directors

  • George G. Klee, MD, PhD

    Chair
    Division of Experimental Pathology
    Mayo Clinic
    Professor of Laboratory Medicine
    Mayo Clinic College of Medicine
    Rochester, Minnesota

  • Iftikhar J. Kullo, MD

    Consultant
    Division of Cardiovascular Diseases
    Mayo Clinic
    Associate Professor of Medicine
    Mayo Clinic College of Medicine
    Rochester, Minnesota

Mayo Clinic Faculty

  • John C. Burnett Jr., MD

    Consultant
    Division of Cardiovascular Diseases
    Mayo Clinic
    Professor of Medicine and Physiology
    Mayo Clinic College of Medicine
    Rochester, Minnesota

  • Cheryl A. Conover, PhD

    Consultant, Endocrine Research Unit
    Division of Endocrinology, Diabetes, Metabolism, Nutrition
    Professor of Medicine Mayo Clinic College o
    f Medicine
    Rochester, Minnesota

  • Thomas C. Gerber, MD, PhD, FACP, FACC, FAHA

    Consultant
    Division of Cardiovascular Diseases and Diagnostic Radiology
    Mayo Clinic
    Associate Professor of Medicine and Radiology
    Mayo Clinic College of Medicine
    Jacksonville, Florida

  • Raymond J. Gibbons, MD

    Immediate Past President
    American Heart Association
    Arthur M. and Gladys D. Gray Professor of Medicine
    Mayo Clinic College of Medicine
    Rochester, Minnesota

  • Joseph P. McConnell, PhD

    Consultant, Cardiovascular Laboratory Medicine
    Division of Clinical Biochemistry and Immunology
    Assistant Professor of Laboratory Medicine and Pathology
    Mayo Clinic College of Medicine
    Rochester, Minnesota

  • Robert D. Simari, MD

    Vice Chair, Cardiovascular Research
    Consultant, Division of Cardiovascular Diseases
    Professor of Medicine
    Mayo Clinic College of Medicine
    Rochester, Minnesota

Guest Faculty

  • Frank J. Accurso, MD

    Director, Cystic Fibrosis Center
    Professor of Pediatrics
    University of Colorado School of Medicine
    Denver, Colorado

  • Nancy R. Cook, ScD

    Associate Professor of Medicine
    Harvard Medical School
    Boston, Massachusetts

  • Robert E. Gerszten, MD

    Cardiology Division and
    Center for Immunology & Inflammatory Diseases
    Associate Professor of Medicine
    Harvard Medical School
    Boston, Massachusetts

  • Steven I. Gutman, MD, MBA

    Office Director
    Office of In Vitro Diagnostic Device Evaluation and Safety
    Food and Drug Administration
    Rockville, Maryland

  • Glen L. Hortin, MD, PhD

    Chief of Clinical Chemistry
    Department of Laboratory Medicine
    National Institutes of Health Clinical Center
    Bethesda, Maryland

  • Mehmood Khan, MD, FACE

    Senior Vice President
    Medical & Scientific Affairs
    Takeda Pharmaceuticals
    Lincolnshire, Illinois

  • Christopher M. Kramer, MD

    Professor of Radiology and Medicine
    Director, Cardiovascular Imaging Center
    University of Virginia Health System
    Charlottesville, Virginia

  • Teri Manolio, MD, PhD

    Senior Advisor to the Director, NHGRI, for Population Genomics
    Director, Office of Population Genomics
    National Human Genome Research Institute
    Professor of Medicine
    F. Edward Herbert School of Medicine
    Uniformed Services University of Health Sciences
    Bethesda, Maryland

  • Willie E. May, PhD

    Director
    Chemical Science and Technology Laboratory
    National Institute of Standards and Technology
    Gaithersburg, Maryland

  • John A. Moon, PhD

    Vice President, Technology
    Illumina Corporation
    Wallingford, Connecticut

  • Fred E. Regnier, MD

    J. H. Law Distinguished Professor
    Analytical Chemistry
    College of Science – Department of Chemistry
    Purdue University
    West Lafayette, Indiana

  • Paul M. Ridker, MD

    Reynolds Investigator & Center Co-Director
    Director, Center for Cardiovascular Disease Prevention
    Brigham and Women’s Hospital
    Eugene Braunwald Professor of Medicine, Harvard Medical School
    Boston, Massachusetts

  • John A. Rumberger, PhD, MD, FACC

    Director of Cardiac Imaging
    The Princeton Longevity Center
    Medical Director
    PrevaHealth Wellness Diagnostic Center
    Professor of Medicine (Clinical)
    Department of Medicine
    The Ohio State University
    Columbus, Ohio

  • Marc S. Sabatine, MD, MPH

    TIMI Study Group
    Brigham and Women’s Hospital
    Assistant Professor of Medicine
    Harvard Medical School
    Boston, Massachusetts

  • Michel E. Safar, MD

    Professor
    Paris Descartes University
    Hypertension and Cardiovascular Prevention Unit
    Diagnosis Center
    Hospital Hotel-Dieu
    Paris, France

  • Pothur R. Srinivas, PhD, MPH

    Program Director
    Division of Cardiovascular Diseases
    National Heart, Lung and Blood Institute
    Bethesda, Maryland

  • Jennifer Van Eyk, PhD

    Director, Center Investigator
    Johns Hopkins University
    Bayview Proteomics Center
    Baltimore, Maryland

  • Renu Virmani, MD

    President and Medical Director
    CVPath Institute, Inc.
    Gaithersburg, Maryland

  • Lorraine B. Ware, MD

    Assistant Professor
    Allergy/Pulmonary & Critical Care Medical Division
    Vanderbilt University
    Nashville, Tennessee

Faculty Disclosure

As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of CME) must ensure balance, independence, objectivity, and scientific rigor in its educational activities. Course director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so that participants in the activity may formulate their own judgments regarding the presentation.

 


Key